Development of BAT8001, a HER2 Antibody Drug Conjugate

Time: 9:10 am

Details:

• Learn about the ADC, effective against tumors resistant to trastuzumab, that has been developed
• Assess clinical studies that have determined the effective dose
• Hear about the GMP compliant production facility that has been constructed to manufacture the commercial product